Skip to main content
. Author manuscript; available in PMC: 2020 Aug 6.
Published in final edited form as: Biol Psychiatry. 2015 Aug 24;79(9):755–764. doi: 10.1016/j.biopsych.2015.08.018

Figure. 3.

Figure. 3.

Ketamine delays the worsening of the respiratory function. (A) Representative plethysmography traces illustrating breathing pattern. (B) Quantification of the number of apneas per minute. Ketamine treatment from P30 prevented the developmental increase of apneic episodes (Wilcoxon signed-rank test, * p < 0.05, ** p ≤ 0.01. WT-v, n = 8; KO-v, n = 11; KO-k15, n = 7; KO-k30, n = 8 mice).